Abnormal folate metabolism in foetuses affected by neural tube defects

Brain

Volumn 130, Issue 4, 2007, Pages 1043-1049

  Dunlevy, Louisa P E ^a   Chitty, Lyn S ^a,b   Burren, Katie A ^a   Doudney, Kit ^a   Stojilkovic Mikic, Taita ^b   Stanier, Philip ^a   Scott, Rosemary ^c   Copp, Andrew J ^a   Greene, Nicholas D E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Napolitano and Prof David)   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Anencephaly; Folate; Neural tube defects; S adenosylhomocysteine; S adenosylmethionine; Spina bifida

Indexed keywords

DEOXYURIDINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; ANTIMETABOLITE; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; FOLIC ACID; METHIONINE SYNTHASE REDUCTASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FETUS; FIBROBLAST; FOLATE METABOLISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METHYLATION; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; ANENCEPHALUS; ANIMAL; CELL STRAIN 3T3; DRUG EFFECT; FEMALE; FETUS DISEASE; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PREGNANCY; PRENATAL DEVELOPMENT;

ANENCEPHALY; ANIMALS; ANTIMETABOLITES; DEOXYURIDINE; FEMALE; FERREDOXIN-NADP REDUCTASE; FETAL DISEASES; FETUS; FIBROBLASTS; FOLIC ACID; GENOTYPE; HUMANS; METHYLATION; MICE; NEURAL TUBE DEFECTS; NIH 3T3 CELLS; POLYMORPHISM, GENETIC; PREGNANCY; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; SPINAL DYSRAPHISM;

EID: 34249690574     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm028     Document Type: Article

References (33)

1. Blom HJ, Shaw GM, den Heijer M, Finnell RH. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 2006; 7: 724-31.
2. Boyle T, Griffin D. The cytogenetics of pregnancy. In: Rooney DE, editor. Human cytogenetics: constitutional analysis. 3rd edn. Oxford: Oxford University Press; 2001.
3. Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet 2005; 135: 9-23.
4. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002; 71: 1207-15.
5. Burren KA, Mills K, Copp AJ, Greene ND. Quantitative analysis of s-adenosylmethionine and s-adenosylhomocysteine in neurulation-stage mouse embryos by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 844: 112-8.
6. Caudill MA, Wang JC, Melnyk S, Pogribny IP, Jernigan S, Collins MD, et al. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine betasynthase heterozygous mice. J Nutr 2001; 131: 2811-8.
7. Copp AJ, Greene NDE, Murdoch JN. The genetic basis of mammalian neurulation. Nat Rev Genet 2003; 4: 784-93.
8. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-5.
9. Dunlevy LPE, Burren KA, Chitty LS, Copp AJ, Greene NDE. Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryos. FEBS Lett 2006a; 580: 2803-7.
10. Dunlevy LPE, Burren KA, Mills K, Chitty LS, Copp AJ, Greene NDE. Integrity of the methylation cycle is essential for mammalian neural tube closure. Birth Defects Res A Clin Mol Teratol 2006b; 76: 544-52.
11. Fleming A, Copp AJ. Embryonic folate metabolism and mouse neural tube defects. Science 1998; 280: 2107-9.
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
13. Gueant-Rodriguez RM, Rendeli C, Namour B, Venuti L, Romanov A, Anello G, et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 2003; 344: 189-92.
14. Habibzadeh N, Schorah CJ, Seller MJ, Smithells RW, Levene MI. Uptake and utilization of DL-5-[methyl-14C] tetrahydropteroylmonoglutamate by cultured cytotrophoblasts associated with neural tube defects. Proc Soc Exp Biol Med 1993; 203: 45-54.
15. Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet 2004; 124A: 339-45.
16. Killman S-A. Effect of deoxyuridine on incorporation of tritiated thymidine: difference between normoblasts and megaloblasts. Acta Med Scand 1964; 175: 483-8.
17. Kirke PN, Mills JL, Molloy AM, Brody LC, O'Leary VB, Daly L, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. Br Med J 2004; 328: 1535-6.
18. 12 are independent risk factors for neural tube defects. Q J Med 1993; 86: 703-8.
19. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000; 71: 121-38.
20. Lucock MD, Daskalakis I, Lumb CH, Schorah CJ, Levene MI. Impaired regeneration of monoglutamyl tetrahydrofolate leads to cellular folate depletion in mothers affected by a spina bifida pregnancy. Mol Genet Metab 1998; 65: 18-30.
21. Lucock MD, Wild J, Lumb CH, Oliver M, Kendall R, Daskalakis I, et al. Risk of neural tube defect-affected pregnancy is associated with a block in maternal one-carbon metabolism at the level of N-5-methyltetrahydrofolate: homocysteine methyltransferase. Biochem Mol Med 1997; 61: 28-40.
22. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345: 149-51.
23. Mills JL, Scott JM, Kirke PN, McPartlin JM, Conley MR, Weir DG, et al. Homocysteine and neural tube defects. J Nutr 1996; 126: 756S-60S.
24. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, et al. 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63: 610-4.
25. Pietrzyk JJ, Bik-Multanowski M, Sanak M, Twardowska M. Polymorphisms of the 5,10-methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida. J Appl Genet 2003; 44: 111-3.
26. Scott JM. Folate and vitamin B12. Proc Nutr Soc 1999; 58: 441-8.
27. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CM, et al. Maternal hyperhomocysteinemia: a risk factor for neural tube defects. Metabolism 1994; 43: 1475-80.
28. Van der Put NMJ, Gabreëls F, Stevens EMB, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects. Am J Hum Genet 1998; 62: 1044-51.
29. Van der Put NMJ, Van Straaten HWM, Trijbels FJM, Blom HJ. Folate, homocysteine and neural tube defects: an overview. Proc Soc Exp Biol Med 2001; 226: 243-70.
30. Vieira AR, Trembath D, Vandyke DC, Murray JC, Marker S, Lerner G, et al. Studies with His475Tyr glutamate carboxipeptidase II polymorphism and neural tube defects. Am J Med Genet 2002; 111: 218-9.
31. Wald N, Sneddon J, Densem J, Frost C, Stone R. MRC Vitamin Study Res Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.
32. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999; 67: 317-23.
33. Zhu H, Wicker NJ, Shaw GM, Lammer EJ, Hendricks K, Suarez L, et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 2003; 78: 216-21.